Literature DB >> 22402775

Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Eiji Oki1, Yuichi Hisamatsu, Koji Ando, Hiroshi Saeki, Yoshihiro Kakeji, Yoshihiko Maehara.   

Abstract

The biological characteristics of cancers depend mostly on genetic alterations in the cancer cells of individuals. Gastric cancers show a high frequency of DNA aneuploidy, a phenotype of chromosomal instability. Compared to diploid tumors, gastric carcinomas with aneuploidy have been shown to have high proliferative activity and high metastatic or invasive potential; these characteristics lead to a poor prognosis. It has been suggested that an abnormal spindle assembly checkpoint is involved in DNA aneuploidy, but the underlying mechanism is still unclear. This review, in order to determine whether gastric carcinomas that display aneuploidy are associated with a poorer prognosis than diploid tumors, and to discuss the biological mechanisms that induce aneuploidy, summarizes the results of studies on DNA ploidy in gastric cancer published in the English literature. Analysis of DNA ploidy in gastric cancer may provide clinically useful information from diagnostic, therapeutic, and prognostic standpoints. Further investigations may be needed to clarify the relationship between chromosome instability and DNA ploidy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22402775     DOI: 10.1007/s00535-012-0565-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  105 in total

1.  Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background.

Authors:  Neil J Toft; Lucy J Curtis; Owen J Sansom; Andrea L Leitch; Andrew H Wyllie; Hein te Riele; Mark J Arends; Alan R Clarke
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

2.  Spindle checkpoint function requires Mad2-dependent Cdc20 binding to the Mad3 homology domain of BubR1.

Authors:  James Davenport; Loleta D Harris; Rakesh Goorha
Journal:  Exp Cell Res       Date:  2006-04-04       Impact factor: 3.905

3.  Chemosensitivity and survival in gastric cancer patients with microsatellite instability.

Authors:  Eiji Oki; Yoshihiro Kakeji; Yan Zhao; Rintaro Yoshida; Koji Ando; Takanobu Masuda; Kippei Ohgaki; Masaru Morita; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2009-06-30       Impact factor: 5.344

4.  MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile.

Authors:  M Pinto; C Oliveira; J C Machado; L Cirnes; J Tavares; F Carneiro; R Hamelin; R Hofstra; R Seruca; M Sobrinho-Simões
Journal:  Lab Invest       Date:  2000-12       Impact factor: 5.662

5.  Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.

Authors:  K Mimori; H Inoue; H Alder; H Ueo; Y Tanaka; M Mori
Journal:  Oncol Rep       Date:  2001 Jan-Feb       Impact factor: 3.906

6.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

7.  Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.

Authors:  Y Yonemura; S Ooyama; K Sugiyama; T Kamata; X De Aretxabala; H Kimura; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

8.  Comparative study between DNA copy number aberrations determined by quantitative microsatellite analysis and clinical outcome in patients with stomach cancer.

Authors:  Seiji Suzuki; Kaku Egami; Koji Sasajima; Mohammad Ghazizadeh; Hajime Shimizu; Hidehiro Watanabe; Hirokazu Hasegawa; Shinya Iida; Takeshi Matsuda; Yuji Okihama; Masaru Hosone; Kazuo Shimizu; Oichi Kawanami; Takashi Tajiri
Journal:  Clin Cancer Res       Date:  2004-05-01       Impact factor: 12.531

9.  Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability.

Authors:  Heike I Grabsch; Jon M Askham; Ewan E Morrison; Natalja Pomjanski; Kristina Lickvers; Wendy J Parsons; Alfred Boecking; Helmut E Gabbert; Wolfram Mueller
Journal:  J Pathol       Date:  2004-02       Impact factor: 7.996

10.  DNA-ploidy in advanced gastric carcinoma is less heterogeneous than in early gastric cancer.

Authors:  Maria-Chiara Osterheld; Liette Caron; Mireille Demierre; Ricardo Laurini; F T Bosman
Journal:  Cell Oncol       Date:  2004       Impact factor: 6.730

View more
  15 in total

1.  PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.

Authors:  Kazuya Shinmura; Nobuya Kurabe; Masanori Goto; Hidetaka Yamada; Hiroko Natsume; Hiroyuki Konno; Haruhiko Sugimura
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

2.  Chromosomal aneuploidies and combinational fluorescence in situ hybridization probe panels are useful for predicting prognosis for esophageal squamous cell carcinoma.

Authors:  Jia-Jie Hao; Han-Qing Yao; Guang-Yun Dai; Wei Kang; Xue-Mei Jia; Xin Xu; Yan Cai; Qi-Min Zhan; Gui-Qi Wang; Ming-Rong Wang
Journal:  J Gastroenterol       Date:  2014-05-11       Impact factor: 7.527

3.  Expression of APPL1 is correlated with clinicopathologic characteristics and poor prognosis in patients with gastric cancer.

Authors:  J S Zhai; J G Song; C H Zhu; K Wu; Y Yao; N Li
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

Review 4.  Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.

Authors:  A J Lucanus; G W Yip
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

Review 5.  Challenges of deciphering gastric cancer heterogeneity.

Authors:  Petra Hudler
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

6.  Overexpression of Eg5 correlates with high grade astrocytic neoplasm.

Authors:  Liqiong Liu; Xichun Liu; Marcus Mare; Aaron S Dumont; Haitao Zhang; Dong Yan; Zhenggang Xiong
Journal:  J Neurooncol       Date:  2015-10-11       Impact factor: 4.130

7.  Contribution of Aurora-A and -B expression to DNA aneuploidy in gastric cancers.

Authors:  Kenichi Honma; Ryota Nakanishi; Tomonori Nakanoko; Koji Ando; Hiroshi Saeki; Eiji Oki; Makoto Iimori; Hiroyuki Kitao; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-04-10       Impact factor: 2.549

8.  Mutation rates, spectra, and genome-wide distribution of spontaneous mutations in mismatch repair deficient yeast.

Authors:  Gregory I Lang; Lance Parsons; Alison E Gammie
Journal:  G3 (Bethesda)       Date:  2013-09-04       Impact factor: 3.154

9.  Kinesin family member 4A: a potential predictor for progression of human oral cancer.

Authors:  Yasuyuki Minakawa; Atsushi Kasamatsu; Hirofumi Koike; Morihiro Higo; Dai Nakashima; Yukinao Kouzu; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hideki Tanzawa; Katsuhiro Uzawa
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

10.  Diagnostic value of negative enrichment and immune fluorescence in situ hybridization for intraperitoneal free cancer cells of gastric cancer.

Authors:  Anqiang Wang; Zhongwu Li; Qian Wang; Yali Bai; Xin Ji; Tao Fu; Ke Ji; Yanwen Xue; Tingxu Han; Xiaojiang Wu; Ji Zhang; Yingjie Yang; Guobin Xu; Zhaode Bu; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2019-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.